de Groot JW - Search Results

1

The effects of four different tyrosine kinase inhibitors on medullary and papillary thyroid cancer cells.

Verbeek HH, Alves MM, de Groot JW, Osinga J, Plukker JT, Links TP, Hofstra RM. Verbeek HH, et al. Among authors: de groot jw. J Clin Endocrinol Metab. 2011 Jun;96(6):E991-5. doi: 10.1210/jc.2010-2381. Epub 2011 Apr 6. J Clin Endocrinol Metab. 2011. PMID: 21470995

2

Medullary thyroid cancer in a patient with Hirschsprung disease with a C609Y germline RET-mutation.

de Groot JW, Sijmons RH, Links TP, Plukker JT, Hofstra RM. de Groot JW, et al. J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):226-9. doi: 10.1097/00005176-200502000-00028. J Pediatr Gastroenterol Nutr. 2005. PMID: 15699703 No abstract available.

3

Imatinib induces hypothyroidism in patients receiving levothyroxine.

de Groot JW, Zonnenberg BA, Plukker JT, van Der Graaf WT, Links TP. de Groot JW, et al. Clin Pharmacol Ther. 2005 Oct;78(4):433-8. doi: 10.1016/j.clpt.2005.06.010. Clin Pharmacol Ther. 2005. PMID: 16198662 Clinical Trial.

4

RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors.

de Groot JW, Links TP, Plukker JT, Lips CJ, Hofstra RM. de Groot JW, et al. Endocr Rev. 2006 Aug;27(5):535-60. doi: 10.1210/er.2006-0017. Epub 2006 Jul 18. Endocr Rev. 2006. PMID: 16849421 Review.

5

Determinants of life expectancy in medullary thyroid cancer: age does not matter.

de Groot JW, Plukker JT, Wolffenbuttel BH, Wiggers T, Sluiter WJ, Links TP. de Groot JW, et al. Clin Endocrinol (Oxf). 2006 Dec;65(6):729-36. doi: 10.1111/j.1365-2265.2006.02659.x. Clin Endocrinol (Oxf). 2006. PMID: 17121523

6

Biochemical markers in the follow-up of medullary thyroid cancer.

de Groot JW, Kema IP, Breukelman H, van der Veer E, Wiggers T, Plukker JT, Wolffenbuttel BH, Links TP. de Groot JW, et al. Thyroid. 2006 Nov;16(11):1163-70. doi: 10.1089/thy.2006.16.1163. Thyroid. 2006. PMID: 17123344

7

Locoregional control in patients with palpable medullary thyroid cancer: results of standardized compartment-oriented surgery.

de Groot JW, Links TP, Sluiter WJ, Wolffenbuttel BH, Wiggers T, Plukker JT. de Groot JW, et al. Head Neck. 2007 Sep;29(9):857-63. doi: 10.1002/hed.20609. Head Neck. 2007. PMID: 17427969

8

18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation.

Koopmans KP, de Groot JW, Plukker JT, de Vries EG, Kema IP, Sluiter WJ, Jager PL, Links TP. Koopmans KP, et al. Among authors: de vries eg, de groot jw. J Nucl Med. 2008 Apr;49(4):524-31. doi: 10.2967/jnumed.107.047720. J Nucl Med. 2008. PMID: 18375923 Free article.

9

Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer.

Walter MA, Meier C, Radimerski T, Iten F, Kränzlin M, Müller-Brand J, de Groot JW, Kema IP, Links TP, Müller B. Walter MA, et al. Among authors: de groot jw. Cancer. 2010 Jan 1;116(1):31-40. doi: 10.1002/cncr.24738. Cancer. 2010. PMID: 19890958 Free article.

10

Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study.

Schreinemakers JM, Vriens MR, Valk GD, de Groot JW, Plukker JT, Bax K, Hamming JF, van der Luijt RB, Aronson DC, Borel Rinkes IH. Schreinemakers JM, et al. Among authors: de groot jw. World J Surg. 2010 Apr;34(4):852-60. doi: 10.1007/s00268-009-0370-2. World J Surg. 2010. PMID: 20063095 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters